Safety and clinical effect of subcutaneous human interleukin-21 in patients with metastatic melanoma or renal cell carcinoma: a phase I trial.

Source:http://linkedlifedata.com/resource/pubmed/id/20959407

Clin. Cancer Res. 2010 Nov 1 16 21 5312-9

Download in:

View as

General Info

PMID
20959407